ライフサイエンスコーパス: vascular cell adhesion molecule-1

1 ffect binding of VLA-4 to its ligand VCAM-1 (vascular cell adhesion molecule 1).

2 ctin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1.

3 f endothelial activation, angiopoietin 2 and vascular cell adhesion molecule 1.

4 nd intercellular adhesion molecule 1 but not vascular cell adhesion molecule 1.

5 llular cell adhesion molecule 1, and soluble vascular cell adhesion molecule 1.

6 in very late antigen 4 binding to its ligand vascular cell adhesion molecule 1.

7 1, interleukin 1beta, interferon gamma, and vascular cell adhesion molecule 1.

8 , IL-16, monocyte chemotactic protein-1, and vascular cell adhesion molecule-1.

9 tumor necrosis factor-mediated expression of vascular cell adhesion molecule-1.

10 mooth muscle cell actin and up-regulation of vascular cell adhesion molecule-1.

11 levels of IL-6, serum amyloid P, and soluble vascular cell adhesion molecule-1.

12 h a peptide mimicking monocyte engagement by vascular cell adhesion molecule-1.

13 natriuretic peptide (NT-proBNP) and soluble vascular cell adhesion molecule-1.

14 late antigen-4 (VLA-4), which interacts with vascular cell adhesion molecule-1.

15 f TRPC3 channels and also B cell adhesion to vascular cell adhesion molecule-1.

16 ha(4)beta(1) and blocks its interaction with vascular cell adhesion molecule-1.

17 1beta-induced expression of IL-6, MCP-1, and vascular cell adhesion molecule-1.

18 on and directed migration on fibronectin and vascular cell adhesion molecule-1.

19 lpha4beta1 and loss of binding to its ligand vascular cell adhesion molecule-1.

20 coclustering within focal adhesive sites on vascular cell adhesion molecule-1.

21 2.84-4.95] vs. 1.66 [1.22-2.63] p < 0.0001), vascular cell adhesion molecule 1 (539 [451-621] vs. 402

22 ctant protein-1 (-13% versus +0.2%), soluble vascular cell adhesion molecule-1 (-6% versus +1%), high

23 Tumour necrosis factor alpha, vascular cell adhesion molecule-1, 8-isoprostane, leptin

24 CpG-induced calcium signals and vascular cell adhesion molecule-1 adhesion are TLR9-inde

25 I domain-mediated cell spreading and soluble vascular cell adhesion molecule-1 (alpha4beta1 ligand)-i

26 oinflammatory proteins, cyclooxygenase-2 and vascular cell adhesion molecule-1 also in an Src kinase

27 Vascular cell adhesion molecule 1, an adhesion molecule

28 d prevented monocyte adhesion by attenuating vascular cell adhesion molecule -1 and monocyte chemoatt

29 marrow depended on constitutively expressed vascular cell adhesion molecule 1 and endothelial select

30 and alphaLbeta2 to their respective ligands, vascular cell adhesion molecule 1 and intercellular adhe

31 es with their endothelial counter-receptors, vascular cell adhesion molecule 1 and intercellular adhe

32 ws for adhesion to their respective ligands, vascular cell adhesion molecule 1 and intercellular adhe

33 There was more intense and widespread vascular cell adhesion molecule-1 and collagen staining

34 decreased firm arrest of mouse monocytes on vascular cell adhesion molecule-1 and E-selectin in a sh

35 pression potently inhibited the induction of vascular cell adhesion molecule-1 and endothelial adhesi

36 1 mRNA levels and inhibited cytokine-induced vascular cell adhesion molecule-1 and intercellular adhe

37 nockout mice showed significant decreases in vascular cell adhesion molecule-1 and intercellular adhe

38 In addition, CLP-increased vascular cell adhesion molecule-1 and intercellular adhe

39 le cells blocks Ang II-induced expression of vascular cell adhesion molecule-1 and intercellular adhe

40 Vascular cell adhesion molecule-1 and intercellular adhe

41 tor T cells adhere to high concentrations of vascular cell adhesion molecule-1 and intercellular adhe

42 rabbits decreased collar-induced endothelial vascular cell adhesion molecule-1 and intercellular adhe

43 lished the blocking effect of kallistatin on vascular cell adhesion molecule-1 and monocyte chemoattr

44 pha-induced NF-kappaB activation, as well as vascular cell adhesion molecule-1 and monocyte chemoattr

45 repressor for inflammatory mediators such as vascular cell adhesion molecule-1 and monocyte chemotact

46 nhanced the expression of adhesion molecules vascular cell adhesion molecule-1 and monocyte chemotact

47 Whereas vascular cell adhesion molecule-1 and P-selectin were no

48 erns of vascular adhesion molecules, such as vascular cell adhesion molecule-1 and platelet endotheli

49 ture, S18886 also prevented the induction of vascular cell adhesion molecule-1 and prevented the decr

50 ctin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 and secretion of the c

51 ntent), and endothelial dysfunction (soluble vascular cell adhesion molecule-1 and soluble intercellu

52 or inhibited adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 and the fibronectin sp

53 nd demyelination by increasing expression of vascular cell adhesion molecule-1 and the transcytosis p

54 ement of tumor necrosis factor alpha-induced vascular cell adhesion molecule-1 and tissue factor expr

55 n, and its interactions with both macrophage Vascular Cell Adhesion Molecule-1 and with extracellular

56 nd their receptors and inhibition of VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercell

57 le p75 tumor necrosis factor alpha receptor, vascular cell adhesion molecule 1, and matrix metallopro

58 selectin, intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and tissue factor mes

59 We measured levels of hsCRP, ICAM-1, vascular cell adhesion molecule 1, and tumor necrosis fa

60 increased C3 deposition and increased AT1-R, vascular cell adhesion molecule-1, and collagen expressi

61 tissues, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expres

62 in, thromboxane B2, 6-ketoprostaglandin F1a, vascular cell adhesion molecule-1, and E-selectin were m

63 molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin.

64 molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin.

65 Intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial leuko

66 of mRNA for adhesion molecules (P-selectin, vascular cell adhesion molecule-1, and intercellular adh

67 protein, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and leptin and decrea

68 or-alpha, intracellular adhesion molecule-1, vascular cell adhesion molecule-1, and monocyte chemotac

69 plasma intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and VEDS probands had

70 Here, we identify vascular cell adhesion molecule 1 as the relevant recept

71 ion of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 as well as production

72 82 augmented adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 but not to the fibrone

73 ontin by 12% (95% CI, -14% to -10%), soluble vascular cell adhesion molecule-1 by 14% (95% CI, -18% t

74 ion of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by, and adhesion of hu

75 e intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1, C-peptide, insulin, a

76 croM, Gal-1 increased eosinophil adhesion to vascular cell adhesion molecule-1, caused redistribution

77 ntercellular adhesion molecule 2 (CD102) and vascular cell adhesion molecule 1 (CD106).

78 and endothelial activation markers (soluble vascular cell adhesion molecule-1) decreased but remaine

79 sposed intercellular adhesion molecule 1 and vascular cell adhesion molecule 1, disruption or looseni

80 sposed intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, disruption or looseni

81 les (intercellular cell adhesion molecule 1, vascular cell adhesion molecule 1, E-selectin, and plate

82 or-alpha, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, endothelial selectin,

83 ighly intercellular adhesion molecule-1- and vascular cell adhesion molecule-1-enriched vertical micr

84 ing in the posttranscriptional regulation of vascular cell adhesion molecule 1 expression and a reduc

85 othelial tumor necrosis factor-alpha-induced vascular cell adhesion molecule 1 expression and monocyt

86 s correlated with a marked reduction in lung vascular cell adhesion molecule 1 expression and product

87 RK5 transcriptional activity and upregulated vascular cell adhesion molecule 1 expression.

88 ing three distinct subsets based on Flt3 and vascular cell adhesion molecule 1 expression.

89 atory biomarkers, and carotid P-selectin and vascular cell adhesion molecule-1 expression by contrast

90 Furthermore, vascular cell adhesion molecule-1 expression in both mou

91 osis factor alpha (TNF alpha) stimulation of vascular cell adhesion molecule-1 expression in endothel

92 romoted superoxide production, and increased vascular cell adhesion molecule-1 expression in human ao

93 L-4F reduced vascular cell adhesion molecule-1 expression induced by

94 ung injury, CPAP-30 and STEP-30/30 increased vascular cell adhesion molecule-1 expression, but the ty

95 ased endothelial ROS production, endothelial vascular cell adhesion molecule-1 expression, matrix met

96 eukocytes was associated with an increase in vascular cell adhesion molecule-1 expression, which itse

97 beta- or tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression.

98 rs treated with beta-blocker showed enhanced vascular cell adhesion molecule-1 expression.

99 yr142-phosphorylated beta-catenin stimulates vascular cell-adhesion molecule-1 expression to increase

100 ased low-density lipoprotein uptake, VCAM-1 (vascular cell adhesion molecule 1) expression, apoptosis

101 esion (intracellular adhesion molecule 1 and vascular cell adhesion molecule 1) genes involved in mye

102 le tumor necrosis factor receptor-1, soluble vascular cell adhesion molecule-1, granulocyte colony-st

103 pression (ie, ET-1, ET-A and ET-B receptors, vascular cell adhesion molecule-1, IL-6, and fractalkine

104 RvE1 or RvD1 inhibited the expressions of vascular cell adhesion molecule-1, IL-8, macrophage infl

105 increased apoptosis and reduced inflammatory vascular cell adhesion molecule-1 immunostaining but no

106 ion of intracellular adhesion molecule 1 and vascular cell adhesion molecule 1 in cells and in kidney

107 ilonRII) cells; IL-4; IL-5; eosinophils, and vascular cell adhesion molecule 1 in the large airways a

108 on of monocyte chemoattractant protein-1 and vascular cell adhesion molecule 1 in wire-injured caroti

109 pendent increase in plasma levels of soluble vascular cell adhesion molecule-1 in sickle mice was not

110 elial cell adhesion molecules E-selectin and vascular cell adhesion molecule-1 in the microvasculatur

111 of endothelial nitric oxide, superoxide, and vascular cell adhesion molecule-1 in vitro improved sign

112 duction in vitro and increased expression of vascular cell adhesion molecule-1 in vivo.

113 ction (intercellular adhesion molecule-1 and vascular cell adhesion molecule-1) in 524 middle-aged wo

114 se 2, intracellular adhesion molecule 1, and vascular cell adhesion molecule 1), increased expression

115 The expression of vascular cell adhesion molecule-1 induced by IgG-APS or

116 olecules (intercellular adhesion molecule-1, vascular cell adhesion molecule-1), inducible nitric oxi

117 leukin-6, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, inducible nitric oxid

118 scular endothelial growth factor receptor-2, vascular cell adhesion molecule 1, intercellular adhesio

119 IL-8, IL-15, and RANTES), adhesion molecule (vascular cell adhesion molecule 1, intercellular adhesio

120 in, von Willebrand factor (VWF), E-selectin, vascular cell adhesion molecule 1, intercellular adhesio

121 ation; downregulated the local expression of vascular cell adhesion molecule-1, intercellular adhesio

122 tly inhibited thrombin-mediated induction of vascular cell adhesion molecule-1, intercellular adhesio

123 EC, increasing the expression of E-selectin, vascular cell adhesion molecule-1, intercellular adhesio

124 Plasminogen activator inhibitor 1, vascular cell adhesion molecule-1, intracellular adhesio

125 NF-kappaB activation also induced vascular cell adhesion molecule 1, keratinocyte chemoatt

126 s/chemokines, leukotriene B(4) (LTB(4)), and vascular cell adhesion molecule 1 levels in the lungs, w

127 receptor 1, hypoxia-inducible factor-1alpha, vascular cell adhesion molecule-1, macrophage scavenger

128 red fluorescence signals with immunoreactive vascular cell adhesion molecule-1, macrophages, and cath

129 only volume-controlled ventilation increased vascular cell adhesion molecule-1 messenger RNA expressi

130 Circulating levels of immunoglobulin A, vascular cell adhesion molecule-1, myeloperoxidase, and

131 nce of early AMD was associated with soluble vascular cell adhesion molecule-1 (odds ratio per SD on

132 As in skin, TNF induces E-selectin and vascular cell adhesion molecule 1 only on venular ECs, w

133 y be effectively replaced by transduction of vascular cell adhesion molecule-1 or intercellular adhes

134 elial cells on immobilized thrombospondin-1, vascular cell adhesion molecule-1, or recombinant N-term

135 with chronic PTSD had a greater increase in vascular cell adhesion molecule-1 over time (B = 0.003,

136 ated with the endothelial activation markers vascular cell adhesion molecule 1 (P < .001 for both) an

137 ecules intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 (P < .05).

138 ellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 (P < 0.05 above bacter

139 ith elevated levels of NT-proBNP and soluble vascular cell adhesion molecule-1 (P< .001).

140 ation was assessed by measurement of soluble vascular cell adhesion molecule 1, P-selectin, L-selecti

141 both diminished inflammation (expression of vascular cell adhesion molecule 1, plaque macrophage con

142 naling in the stromal cells and with reduced vascular cell adhesion molecule 1 production by them.

143 LDL, Db-HAGE-LDL induced significant soluble vascular cell adhesion molecule-1 production (2.3-fold),

144 ivo with the Ad-Nnat increased expression of vascular cell adhesion molecule 1 protein.

145 binant intercellular adhesion molecule 1 and vascular cell adhesion molecule-1 rather than endothelia

146 cells adhering to culture plates coated with vascular cell adhesion molecule 1, SDF-1 and stem cell f

147 lular adhesion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1, soluble E-selectin, a

148 steopontin), and leukocyte adhesion (soluble vascular cell adhesion molecule-1, soluble intracellular

149 ion of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 surface expression in

150 r adhesion molecule 1 (sICAM-1), and soluble vascular cell adhesion molecule 1 (sVCAM-1) were measure

151 r adhesion molecule 1 (sICAM-1), and soluble vascular cell adhesion molecule 1 (sVCAM-1).

152 othelial growth factor (VEGF) and/or soluble vascular cell adhesion molecule-1 (sVCAM-1) are associat

153 Soluble vascular cell adhesion molecule-1 (sVCAM-1) is a marker

154 rix metalloproteinase 9 (MMP-9), and soluble vascular cell adhesion molecule-1 (sVCAM-1) were dramati

155 ercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) were higher

156 intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin

157 ivo magnetic resonance imaging enhanced with vascular cell adhesion molecule-1-targeted nanoparticles

158 alpha receptor 2, interleukin-6, and soluble vascular cell adhesion molecule-1 to the 20-year cumulat

159 of the p65 subunit of NF-kappaB to increase vascular cell adhesion molecule-1 transcription.

160 We suggest that lymphocyte binding to vascular cell adhesion molecule 1 triggers a signaling p

161 olecules (intercellular adhesion molecule-1, vascular cell adhesion molecule-1), tumor necrosis facto

162 selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, tumor necrosis factor

163 ing of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 under the migrating le

164 shear stress to alpha4beta1 integrin ligands vascular cell adhesion molecule 1 (VCAM-1) and fibronect

165 In mice lacking endothelial vascular cell adhesion molecule 1 (VCAM-1) and in wild-t

166 elial dysfunctional markers, such as soluble vascular cell adhesion molecule 1 (VCAM-1) and intercell

167 Antibody neutralization of vascular cell adhesion molecule 1 (VCAM-1) and its ligan

168 The levels of soluble vascular cell adhesion molecule 1 (VCAM-1) and osteoprot

169 tudies revealed that the interaction between vascular cell adhesion molecule 1 (VCAM-1) and very late

170 Vascular cell adhesion molecule 1 (VCAM-1) expression, h

171 However, blocking VLA-4 or vascular cell adhesion molecule 1 (VCAM-1) had no effect

172 endothelial CD40, which allowed induction of vascular cell adhesion molecule 1 (VCAM-1) in a CD40-dep

173 Although expression of vascular cell adhesion molecule 1 (VCAM-1) in endothelia

174 tercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in the lungs

175 (17-beta E(2)) attenuates the expression of vascular cell adhesion molecule 1 (VCAM-1) in vivo at ph

176 but interaction with the endothelial ligand vascular cell adhesion molecule 1 (VCAM-1) may also play

177 neutrophils adhering to surfaces expressing vascular cell adhesion molecule 1 (VCAM-1) motivated the

178 Vascular cell adhesion molecule 1 (VCAM-1) plays a major

179 strate that the adhesion pathway mediated by vascular cell adhesion molecule 1 (VCAM-1) plays a role

180 s is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated o

181 uman umbilical vein endothelial cell (HUVEC) vascular cell adhesion molecule 1 (VCAM-1) upregulation.

182 Levels of vascular cell adhesion molecule 1 (VCAM-1) were measured

183 Here, we show that red pulp vascular cell adhesion molecule 1 (VCAM-1)(+) macrophage

184 d serves as an adhesive ligand that captures vascular cell adhesion molecule 1 (VCAM-1)(+) metastatic

185 -activated antibody (pro-antibody) targeting vascular cell adhesion molecule 1 (VCAM-1), a marker of

186 e chemotactic protein 1 (MCP-1), IL-6, IL-8, vascular cell adhesion molecule 1 (VCAM-1), and E-select

187 intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-select

188 essential for TNF-alpha-induced E-selectin, vascular cell adhesion molecule 1 (VCAM-1), and intercel

189 e (ADMA), intercellular adhesion molecule 1, vascular cell adhesion molecule 1 (VCAM-1), and monocyte

190 FimA, while RANTES, gamma interferon, IL-17, vascular cell adhesion molecule 1 (VCAM-1), and vascular

191 d factor, intracellular adhesion molecule 1, vascular cell adhesion molecule 1 (VCAM-1), E-selectin,

192 aluate expression of an inflammatory marker, vascular cell adhesion molecule 1 (VCAM-1), in atheroscl

193 ment and adherence to endothelium, including vascular cell adhesion molecule 1 (VCAM-1), intercellula

194 endothelial cells to synthesize E-selectin, vascular cell adhesion molecule 1 (VCAM-1), interleukin

195 ed significantly increased urinary levels of vascular cell adhesion molecule 1 (VCAM-1), P-selectin,

196 intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), platelet-end

197 ody fragment directed against mouse or human vascular cell adhesion molecule 1 (VCAM-1), recently has

198 acrophage chemoattractant protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1), secretory ph

199 al variables, including the level of soluble vascular cell adhesion molecule 1 (VCAM-1), were assesse

200 cells to express adhesion molecules such as vascular cell adhesion molecule 1 (VCAM-1), which mediat

201 effect was specific for L-selectin, because vascular cell adhesion molecule 1 (VCAM-1)-mediated adhe

202 d intercellular adhesion molecule 1 (ICAM-1)/vascular cell adhesion molecule 1 (VCAM-1)-mediated adhe

203 uantitative behavioral outcomes, and a novel vascular cell adhesion molecule 1 (VCAM-1)-targeted magn

204 yte adhesion molecules (ELAM) E-selectin and vascular cell adhesion molecule 1 (VCAM-1).

205 of a4 integrins on the MCp with endothelial vascular cell adhesion molecule 1 (VCAM-1).

206 ell binding is mediated by receptors such as vascular cell adhesion molecule 1 (VCAM-1).

207 RBC adhesion to a known alpha4beta1 ligand, vascular cell adhesion molecule 1 (VCAM-1).

208 late antigen 4 (VLA-4)-mediated adhesion to vascular cell adhesion molecule 1 (VCAM-1).

209 tercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1).

210 adhesion of eosinophils to various forms of vascular cell adhesion molecule 1 (VCAM-1, CD106), an in

211 Vascular cell adhesion molecule 1 (VCAM-1; CD106), a mem

212 In vivo molecular imaging of vascular cell adhesion molecule-1 (VCAM 1) P-selectin, a

213 lated up-regulation of the adhesion proteins vascular cell adhesion molecule-1 (VCAM) and intercellul

214 /mL, Group II: 0.14 (0.20) mug/mL, P = .02); vascular cell adhesion molecule-1 (VCAM-1) (Group I: 0.3

215 Binding of leukocytes to vascular cell adhesion molecule-1 (VCAM-1) activates sig

216 d by inhibition of TNF-induced expression of vascular cell adhesion molecule-1 (VCAM-1) and could be

217 ercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) and diabetes

218 levels than PDEs of the endothelial proteins vascular cell adhesion molecule-1 (VCAM-1) and endotheli

219 mposed of B78H1 cells transfected with human vascular cell adhesion molecule-1 (VCAM-1) and human mon

220 n inhibitory factor (rhMIF) in up-regulating vascular cell adhesion molecule-1 (VCAM-1) and intercell

221 Endothelial vascular cell adhesion molecule-1 (VCAM-1) and its ligan

222 ry signaling that controls expression of the vascular cell adhesion molecule-1 (VCAM-1) and monocyte

223 177 as well as expression of redox-sensitive vascular cell adhesion molecule-1 (VCAM-1) and monocyte

224 uction of the endothelial activation markers vascular cell adhesion molecule-1 (VCAM-1) and vascular

225 was abolished by CD29 blockade on hMSCs and vascular cell adhesion molecule-1 (VCAM-1) blockade on H

226 tercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression by

227 tion, EGF treatment induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) expression in

228 Vascular cell adhesion molecule-1 (VCAM-1) expression wa

229 cells was p38 MAPK-dependent while increased vascular cell adhesion molecule-1 (VCAM-1) expression wa

230 We hypothesized that molecular imaging of vascular cell adhesion molecule-1 (VCAM-1) expression wi

231 brain inflammation was used to induce global vascular cell adhesion molecule-1 (VCAM-1) expression.

232 iency also transiently augmented LPS-induced vascular cell adhesion molecule-1 (VCAM-1) expression.

233 e derivatives as novel, potent inhibitors of vascular cell adhesion molecule-1 (VCAM-1) expression.

234 y Wu et al presents additional evidence that vascular cell adhesion molecule-1 (VCAM-1) imaging in at

235 pression of inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) in cultured r

236 wnstream target genes tissue factor (TF) and vascular cell adhesion molecule-1 (VCAM-1) in diabetic a

237 timulates the expression of pro-inflammatory vascular cell adhesion molecule-1 (VCAM-1) in endothelia

238 (1-100 microm) stimulated the expression of vascular cell adhesion molecule-1 (VCAM-1) in human coro

239 ur angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary cu

240 Vascular cell adhesion molecule-1 (VCAM-1) is a cell sur

241 Vascular cell adhesion molecule-1 (VCAM-1) is expressed

242 very late antigen-4 (VLA-4) with its ligand vascular cell adhesion molecule-1 (VCAM-1) is required f

243 tensile forces in their normal function, and vascular cell adhesion molecule-1 (VCAM-1) is typical in

244 croarray analysis of P0 and P3 revealed that vascular cell adhesion molecule-1 (VCAM-1) is up-regulat

245 vasive imaging of adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) may identify

246 Vascular cell adhesion molecule-1 (VCAM-1) mediates recr

247 ctions mediated via alpha4beta1 integrin and vascular cell adhesion molecule-1 (VCAM-1) on myeloma ce

248 free of endotoxin were incapable of inducing vascular cell adhesion molecule-1 (VCAM-1) or tumor necr

249 (very late activation antigen-4 [VLA-4]) and vascular cell adhesion molecule-1 (VCAM-1) play a major

250 dhesion mediated by integrin alpha4beta1 and vascular cell adhesion molecule-1 (VCAM-1) plays a cruci

251 Vascular cell adhesion molecule-1 (VCAM-1) plays importa

252 ApoCIII increased EC expression of vascular cell adhesion molecule-1 (VCAM-1) protein and i

253 cess on CXC chemokine receptor 2 (CXCR2) and vascular cell adhesion molecule-1 (VCAM-1) using null st

254 y associated with survival were defined, and vascular cell adhesion molecule-1 (VCAM-1) was the gene

255 bit neurite outgrowth on recombinant soluble vascular cell adhesion molecule-1 (VCAM-1), a known liga

256 effect of t-RA exposure on cell adhesion to vascular cell adhesion molecule-1 (VCAM-1), a well-estab

257 intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-select

258 e synthase (iNOS), cyclooxygenase-2 (COX-2), vascular cell adhesion molecule-1 (VCAM-1), and manganes

259 rcellular adhesion molecule-1 (ICAM-1), anti-vascular cell adhesion molecule-1 (VCAM-1), anti-fibrin,

260 cellular adhesion molecule-1 (MAdCAM-1) and vascular cell adhesion molecule-1 (VCAM-1), endothelial

261 ion strengthening on the alpha4beta1 ligand, vascular cell adhesion molecule-1 (VCAM-1), in shear flo

262 ctivator 2, decay accelerating factor (DAF), vascular cell adhesion molecule-1 (VCAM-1), manganese su

263 acrophage chemoattractant protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), nuclear fact

264 lium and subsequent induction of endothelial vascular cell adhesion molecule-1 (VCAM-1), which is req

265 with very late antigen-4 (VLA-4) binding to vascular cell adhesion molecule-1 (VCAM-1), which is upr

266 ssing the endothelial cell adhesion molecule vascular cell adhesion molecule-1 (VCAM-1), which normal

267 ly as a consequence of reduced expression of vascular cell adhesion molecule-1 (VCAM-1), which regula

268 FGF-4 and SDF-1 enhanced vascular cell adhesion molecule-1 (VCAM-1)- and very lat

269 hase and underwent firm adhesion mediated by vascular cell adhesion molecule-1 (VCAM-1).

270 on oxide that enables imaging of endothelial vascular cell adhesion molecule-1 (VCAM-1).

271 nflammatory activation involving exposure of vascular cell adhesion molecule-1 (VCAM-1).

272 tracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

273 tracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

274 binds to its main ligands, fibronectin, and vascular cell adhesion molecule-1 (VCAM-1).

275 dependent adhesion of SS RBCs to immobilized vascular cell adhesion molecule-1 (VCAM-1).

276 tercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

277 ant protein-1 (MCP-1) and 36% lower lesional vascular cell adhesion molecule-1 (VCAM-1).

278 key cytokines, and cell adhesion molecules (vascular cell adhesion molecule 1 [VCAM-1] and intracell

279 issue inhibitor of metalloproteinases 1; and vascular cell adhesion molecule 1 [VCAM-1]) were measure

280 ts of SLPs (fibrinogen, fibronectin, soluble vascular cell adhesion molecule-1 [VCAM-1], intercellula

281 ty lipoprotein (VLDL)-stimulated endothelial vascular cell adhesion molecule 1 (VCAM1) induction and

282 of intercellular adhesion molecule 1 (ICAM1)/vascular cell adhesion molecule 1 (VCAM1), whose express

283 eduction of the proinflammatory cell surface vascular cell adhesion molecule 1 (VCAM1).

284 ic kidney, which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late

285 Vascular cell adhesion molecule-1 (VCAM1) constitutes a

286 evels of the adhesion and signaling molecule vascular cell adhesion molecule-1 (VCAM1).

287 F-kappaB-responsive genes, but expression of vascular cell-adhesion molecule-1 (Vcam1) was particular

288 , vascular endothelial growth factor [VEGF], vascular cell adhesion molecule 1 [VCAM1], and GTP bindi

289 Although vascular cell adhesion molecule-1 (VLA-4 receptor) was e

290 ellular adhesion molecule 1, E-selectin, and vascular cell adhesion molecule 1 was up-regulated on th

291 mooth muscle cell actin, and upregulation of vascular cell adhesion molecule-1 was also suppressed in

292 ctin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1) was slightly up- or d

293 ntercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 were reduced after whe

294 , and monocyte chemoattractant protein-1 and vascular cell adhesion molecule-1 were reduced.

295 let), E-selectin (selectin endothelium), and vascular cell adhesion molecule 1, were also upregulated

296 In addition, NanS also modified vascular cell adhesion molecule 1, which orchestrates th

297 ecules intracellular adhesion molecule-1 and vascular cell adhesion molecule-1, which caused a fourfo

298 se-9, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1, which might act in co

299 iency of monocytes sheared in whole blood on vascular cell adhesion molecule-1, while characterizing

300 idase [MPO], matrix metalloproteinase 9, and vascular cell adhesion molecule 1) would be increased an